Skip to content
OpenCapital
Collapse sidebar
Watchlist
Screener
Filings
Earnings
Charts
Collapse sidebar
Screener
Stocks
BioMarin Pharmaceuticals
Business Segments
Products & Services
Payment received as percentage of net product sales
Payment received as percentage of net product sales
BioMarin Pharmaceuticals
·
Products & Services
·
1 segment
Breakdown
Segments
ALDURAZYME
View metric
Watchlist
Screener
Filings
Earnings
Charts
Quarterly
Annual
TTM
Segment
Q4 '23
Q4 '24
Q4 '25
ALDURAZYME
50%
50%
50%
Total
50%
50%
50%